Search results for "biopharma 4.0"

Article Outsourcing Trends in Biopharmaceutical Manufacturing
The author highlights the top 10 outsourcing trends revealed during a survey of biopharmaceutical manufacturers. The biopharmaceutical industry is changing the way it manufactures. According to …

Article Quality Considerations for Using AI in Bio/Pharma
The use of artificial intelligence (AI) is seeing a surge in a variety of industries. But does the regulated nature of bio/pharmaceutical development, manufacturing, and commercialization ser…

Article From Bottlenecks to Breakthroughs: Mastering Buffer Management
Unlock innovation in manufacturing by optimizing your buffer production. Agenda - Options to intensify buffer preparation from using pre-made buffers or buffer concentrates to impl…

Article Alternative solutions to separate AAV full and empty capsids using anion exchange
Adeno-associated virus (AAV) is the main vector for gene therapy and there is need for scalable, cost-efficient, and robust chromatography-based purification. Key for a successful process are …

Article Fast Trak™ training and education courses for 2024
Up your game: keep your skills sharp with one of Cytiva's Fast Trak trainings. Dates for 2024 events are live! Find out more

Article Chromatography innovations for the diversified antibody pipeline
Introducing MabSelect™ VH3 affinity resin for antibody variants At Cytiva, we connect with process developers and manufacturers to understand their needs and strive to make t…

Article Interactive eBook - Understand and unlock the potential of digital scaling
Ready for smarter scaling? Explore the possibilities with a digital process to reduce time and costs associated with your operations. Get started by downloading our free eBook. DOWNLOAD EBO…

Article Democratizing GMP Manufacturing for the New Therapeutic Pipeline
PharmTech Europe discusses technology that enables the “democratization” of mRNA manufacturing with Scott Ripley, general manager, Nucleic Acid Therapeutics and Precision Nanosystems, Cytiva, …

Article Discussing the Origins of the mRNA Therapeutics Field
Andy Geall, co-founder and chief development officer at Replicate Bioscience, discusses the historical context and buildup of the mRNA therapeutics field. Watch video

Article How can you harness the potential of nucleic acid therapeutics?
At Cytiva, the new team is here to support you. We can help you throughout the development of your manufacturing workflow for oligonucleotides and the purification of mRNA drug subs…

Previous PageNext Page